Characterisation & Predictive Value of the Human Cellular Immune Response to Chemoimmunotherapy with Cisplatin Pemetraxed & CD40 Activation

    StatusFinished
    Effective start/end date1/01/1231/12/12

    Funding

    • Cancer Council Australia